DNA binding chelates for nonviral gene delivery imaging

Gene Therapy

Volumn 8, Issue 7, 2001, Pages 515-522

  Bogdanov A , Jr ^a   Tung, C H ^a   Bredow, S ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chelate; Expression vector; Gene delivery; Nuclear imaging; Technetium

Indexed keywords

AMINO ACID; CELL NUCLEUS DNA; CHELATING AGENT; DNA; DNA BINDING PROTEIN; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN; LIPID; MARKER; MESSENGER RNA; PERTECHNETIC ACID TC 99M; PHOSPHORUS 32; PSORALEN; TECHNETIUM; TRACER; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BIODEGRADATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; CYTOMEGALOVIRUS; DNA BINDING; EXPRESSION VECTOR; EXTRACTION; GEL PERMEATION CHROMATOGRAPHY; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INJECTION SITE; KINETICS; LIVER; LUNG; MELANOMA B16; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; ULTRAVIOLET IRRADIATION;

ANIMALS; CHELATING AGENTS; DNA; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; TECHNETIUM; TISSUE DISTRIBUTION; TRANSFECTION;

ANIMALIA; CYTOMEGALOVIRUS;

EID: 0035040575     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301410     Document Type: Article

References (39)

1. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy
2. The development of in vivo imaging systems to study gene expression
3. A 'smart' magnetic resonance imaging agent that reports on specific enzymatic activity
4. MR imaging of gene delivery to the central nervous system with an artificial vector
5. Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants
6. Mapping the in vivo distribution of Herpes simplex virions
7. Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5)
8. Targeting of green fluorescent protein expression to the cell surface
9. Sequence specificity of psoralen photobinding to DNA: A quantitative approach
10. Psoralen-deoxyribonucleic acid photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5′8-trimethylpsoralen
11. Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis
12. Graft copolymers as carriers for systemic delivery of expression vectors
13. Nomenclature for synthetic gene delivery systems
14. Prospects for synthetic self-assembling systems in gene delivery
15. DNA vaccines
16. Liver-directed gene therapy: Promises, problems and prospects at the turn of the century
17. Human gene therapy
18. Naked DNA transport and expression in mammalian cells
19. Nonviral strategies for gene therapy
20. Non-viral peptide-based approaches to gene delivery
21. Gene chemistry: Functionally and conformationally intact fluorescent plasmid DNA
22. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
23. Mechanism of oligonucleotide release from cationic liposomes
24. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection
25. Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET)
26. Rapid nuclear accumulation of injected oligodeoxyribonucleotides
27. PNA-dependent gene chemistry: Stable coupling of peptides and oligonucleotides to plasmid DNA
28. Novel method for covalent fluorescent labeling of plasmid DNA that maintains structural integrity of the plasmid
29. Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics
30. Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood
31. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA)
32. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA
33. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
34. Combination gene therapy for salivary gland cancer
35. Gene therapy - Phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol
36. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer
37. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
38. Adenovirus-mediated p53 gene therapy for human gliomas
39. Design of metal-binding green fluorescent protein variants